Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Branchburg , New Jersey"


14 mentions found


Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. The firm also has several lawyers whose reputations would carry weight with the Justice Department and the FDA, including former Attorney General Eric Holder, legal experts said. ANSWERING DIFFERENT QUESTIONSThe company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. The memo denies the company made false statements to the FDA. The company memo said Lilly couldn’t substantiate allegations that employees faced retaliation for refusing to make false statements.
Persons: Eli Lilly, Mike Segar, Lilly, Burling, Nellie Clark, Kathryn Beiser, Clark, Covington, it’s, , Paul Pelletier, Eric Holder, Gerald Masoudi, Masoudi, Amrit Mula, Mula, Trump, New Jersey Democrat Bob Menendez, ” Menendez Organizations: Reuters, U.S . Justice, Company, REUTERS, U.S . Food, Drug Administration, Washington D.C, Covington, Burling LLP, Justice Department, U.S . Securities, Exchange Commission, Justice, U.S, Department, FDA, New, New Jersey Democrat Locations: New Jersey, Branchburg , New Jersey, , New Jersey, Washington, Covington, Mula, U.S
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. If the Justice Department concludes that an internal investigation was thorough, it can result in a non-prosecution agreement with few, if any, penalties, the experts said. The firm also has several lawyers whose reputations would carry weight with the Justice Department and the FDA, including former Attorney General Eric Holder, legal experts said. ANSWERING DIFFERENT QUESTIONSThe company-backed investigation was based on interviews with more than 100 people, the May 20 memo to Lilly employees said. The company memo said Lilly couldn’t substantiate allegations that employees faced retaliation for refusing to make false statements.
Persons: Eli Lilly, Mike Segar, LLY.N, Lilly, Burling, Nellie Clark, Kathryn Beiser, Clark, Covington, it’s, , Paul Pelletier, Eric Holder, Gerald Masoudi, Masoudi, Amrit Mula, Mula, Trump, New Jersey Democrat Bob Menendez, Menendez Organizations: Company, REUTERS, U.S . Justice, Reuters, U.S . Food, Drug Administration, Washington D.C, Covington, Burling LLP, Justice Department, U.S . Securities, Exchange Commission, Justice, U.S, Department, FDA, New, New Jersey Democrat, Thomson Locations: Branchburg , New Jersey, New Jersey, , New Jersey, Washington, Covington, Mula, U.S
Stocks making the biggest moves midday: AMC, Carnival and Eli Lilly
  + stars: | 2021-06-07 | by ( Hannah Miao | ) www.cnbc.com + 0.00   time to read: +3 min
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. AMC Entertainment — The meme stock jumped another 17% in heavy trading following an 83% rally last week. Meme stocks — Other meme stocks also rose on Monday, mirroring AMC's rally. Carnival, Norwegian and Royal Caribbean — Cruise stocks rose on Monday after Carnival confirmed plans for a July restart. Concrete – Shares of the concrete supplier soared 29% after the company announced it will be acquired by construction materials maker Vulcan Materials.
Persons: Eli Lilly, Koss, Biogen's, Morgan Stanley, — CNBC's Maggie Fitzgerald, Tanaya Macheel, Jesse Pound, Yun Li Organizations: Company, AMC Entertainment, The Securities, Exchange Commission, BlackBerry, GameStop, Royal Caribbean, Carnival, Royal, , Progressive, Vulcan Materials Locations: Branchburg , New Jersey, Royal Caribbean, American, U.S
U.S. issues subpoena to Eli Lilly over New Jersey manufacturing plant
  + stars: | 2021-05-27 | by ( Reuters Staff | ) www.reuters.com sentiment -0.99   time to read: 1 min
FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar(Reuters) - Eli Lilly and Co has received a subpoena from the U.S. Department of Justice, requesting certain documents relating to its manufacturing site in Branchburg, New Jersey, the drugmaker said in a filing on Thursday.
Persons: Eli Lilly, Mike Segar Organizations: Company, REUTERS, U.S . Department of Justice Locations: Branchburg , New Jersey
Eli Lilly receives DoJ subpoena over New Jersey manufacturing plant
  + stars: | 2021-05-27 | by ( Reuters Staff | ) www.reuters.com sentiment -0.99   time to read: +1 min
FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar(Reuters) - Eli Lilly and Co has received a subpoena from the U.S. Department of Justice related to its New Jersey plant that makes its COVID-19 treatment, the drugmaker said in a filing on Thursday. Lilly said it had previously engaged external counsel to conduct an independent investigation of certain allegations relating to the Branchburg plant. “Lilly is deeply committed to manufacturing high-quality medicines for patients who need them, and the safety and quality of our products is our highest priority,” the company said. Reuters reported earlier this month that the company’s employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the manufacturing site in Branchburg, New Jersey.
Persons: Eli Lilly, Mike Segar, Lilly, “ Lilly Organizations: Company, REUTERS, U.S . Department of Justice, Reuters, U.S . Food, Drug Administration Locations: Branchburg , New Jersey, New Jersey
Eli Lilly receives DoJ subpoena over COVID-19 drug manufacturing plant
  + stars: | 2021-05-27 | by ( Reuters Staff | ) www.reuters.com sentiment -1.00   time to read: +1 min
FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar(Reuters) -Eli Lilly and Co said on Thursday it had received a subpoena from the U.S. Department of Justice related to its New Jersey plant that makes its COVID-19 treatment, bamlanivimab. The subpoena requested certain documents relating to its site in Branchburg, New Jersey, and the company is cooperating with the investigation, Eli Lilly said. Eli Lilly is also under pressure due to quality control, production and regulatory issues at its Indianapolis plant, which bottles bamlanivimab, among other drugs. Last year, Eli Lilly hired an independent consultant to review the New Jersey plant after receiving an Official Action Indicated notice from the U.S. health regulator.
Persons: Eli Lilly, Mike Segar, drugmaker Organizations: Company, REUTERS, U.S . Department of Justice, Reuters, U.S . Food Locations: Branchburg , New Jersey, New Jersey, U.S, Indianapolis, Jersey
Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. Lilly said it had previously engaged external counsel to conduct an independent investigation of certain allegations relating to the Branchburg plant. The Justice Department inquiry, which involves U.S. prosecutors and other officials in New Jersey and Washington, began in recent weeks, the three people said. Justice Department and FDA representatives in Washington had no immediate comment on the probe. “This is a big deal,” Lynn said of the Justice Department decision to launch a criminal probe of Lilly, echoing three industry and regulatory experts interviewed by Reuters.
Persons: Eli Lilly, Mike Blake, Lilly, Steven Lynn, ” Lynn, , Trump, Amrit Mula, Mula, Lydia Wible, Wible, Burling, Gerald Masoudi Organizations: REUTERS, . Justice Department, U.S . Food, Drug Administration, Reuters, Justice Department, The, Department, Federal Bureau of Investigation, New, New Jersey U.S, FBI, Manufacturing, ‘ OFFICIAL, FDA, Covington, Burling LLP, Thomson Locations: San Diego , California, U.S, Branchburg , New Jersey, New Jersey, Washington, Branchburg, Covington
The US opened a criminal probe into an Eli Lilly plant that makes COVID-19 vaccines and other drugs. The FDA has been looking into the plant for alleged manufacturing violations for over a year. An ex-FDA head said the US rarely seeks criminal charges from manufacturing violations: "This is a big deal." The Justice Department inquiry, which involves U.S. prosecutors and other officials in New Jersey and Washington, began in recent weeks, the three people said. Justice Department and FDA representatives in Washington had no immediate comment on the probe.
Persons: Eli Lilly, Lilly, Read, Steven Lynn, Lynn, Trump, Amrit Mula, Mula, Lydia Wible, Wible, Burling, Gerald Masoudi, Marisa Taylor, Mike Spector, Dan Levine, Michele Gershberg, Julie Marquis Organizations: US, FDA, US Justice Department, US Food and Drug Administration, Reuters, Justice Department, The Justice Department, The, Department, Federal Bureau of Investigation, New, New Jersey US, FBI, Manufacturing, Covington, Burling LLP, Washington , D.C Locations: Branchburg , New Jersey, New Jersey, Washington, Branchburg, Covington, Washington ,, New York, San Francisco
FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike SegarThe unsigned report, filed April 8 in Lilly’s confidential employee complaint system and reviewed by Reuters, is the latest sign of manufacturing problems at the drug giant. Contacted by Reuters for this story, Lilly confirmed it had received the recent employee complaint about the Branchburg plant. Reuters could not independently confirm that the Branchburg plant was not releasing bamlanivimab to the Indianapolis bottling plant or other facilities. Lilly and the FDA have not responded to questions from Reuters about whether this requirement was carried out.
Persons: Eli Lilly, Lilly, Mike Segar, Lilly’s, , Kathryn Beiser, “ Lilly, ” Lilly, Lydia Wible, David Ricks, Nathan Cortez, Wible, Amrit Mula, Mula, Leanne Hickman, Hickman, Trump, Steven Lynn Organizations: Reuters, Company, REUTERS, U.S . Food, Drug Administration, FDA, Lilly, U.S . Department of Health, Human Services, Southern Methodist University in, Manufacturing Locations: U.S, Branchburg , New Jersey, United States, Indianapolis, Branchburg, Southern Methodist University in Texas, Mula, New Jersey
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. The unsigned report, filed April 8 in Lilly’s confidential employee complaint system and reviewed by Reuters, is the latest sign of manufacturing problems at the drug giant. Contacted by Reuters for this story, Lilly confirmed it had received the recent employee complaint about the Branchburg plant. Reuters could not independently confirm that the Branchburg plant was not releasing bamlanivimab to the Indianapolis bottling plant or other facilities. Lilly and the FDA have not responded to questions from Reuters about whether this requirement was carried out.
Persons: Eli Lilly, Mike Segar Eli Lilly, Lilly, Lilly’s, , Kathryn Beiser, “ Lilly, ” Lilly, Lydia Wible, David Ricks, Nathan Cortez, Wible, Amrit Mula, Mula, Leanne Hickman, Hickman, Trump, Steven Lynn Organizations: Company, REUTERS, Reuters, U.S . Food, Drug Administration, FDA, Lilly, U.S . Department of Health, Human Services, Southern Methodist University in, Manufacturing, Thomson Locations: Branchburg , New Jersey, U.S, United States, Indianapolis, Branchburg, Southern Methodist University in Texas, Mula, New Jersey
Eli Lilly misses profit estimates on lower Covid drug demand
  + stars: | 2021-04-27 | by ( ) www.cnbc.com sentiment -1.00   time to read: +1 min
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Drugmaker Eli Lilly on Tuesday missed analysts' estimates for first-quarter profit and tightened its forecast for full-year adjusted earnings, partly due to lower demand for its Covid-19 drugs. Lilly earned $810.1 million from its Covid-19 drugs in the quarter, below estimates of $985 million, according to Guggenheim analysts. Sales from Covid-19 drugs are now expected in the range of $1 billion to $1.5 billion from $1 billion to $2 billion projected previously. Excluding items, the company earned $1.87 per share, missing estimates of $2.13 per share, according to IBES data from Refinitiv.
Persons: Eli Lilly, Drugmaker Eli Lilly, Lilly, Regeneron Organizations: Company, Guggenheim Locations: Branchburg , New Jersey, U.S, United States
Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab
  + stars: | 2021-04-16 | by ( ) www.reuters.com sentiment -1.00   time to read: +1 min
A sign is pictured outside an Eli Lilly and Company pharmaceutical manufacturing plant at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Hospitals with bamlanivimab supply should now order etesevimab to pair with it, Lilly said. Earlier this week, Lilly revised its pact with the U.S. government to enable the supply of etesevimab to complement doses of bamlanivimab that the government had already purchased. read moreEtesevimab and bamlanivimab together neutralize more emerging COVID-19 variants in the U.S. than bamlanivimab alone, including the rapidly growing B.1.427/B.1.429 California strain, Lilly said on Friday. Lilly said it was not seeking cancellation of bamlanivimab's authorization in other countries, but its use was preferred in combination with etesevimab.
Persons: Eli Lilly, Mike Segar Eli Lilly, Lilly, Amgen Organizations: Company, REUTERS, U.S . Food, Drug Administration, U.S, Thomson Locations: Branchburg , New Jersey, U.S, California
Eli Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab
  + stars: | 2021-04-16 | by ( ) www.cnbc.com sentiment -1.00   time to read: +1 min
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. Eli Lilly said it had requested for cancellation of the U.S. authorization granted to its Covid-19 antibody, bamlanivimab, which will now be used in combination with another to achieve greater efficacy against emerging virus variants. Hospitals with bamlanivimab supply should now order etesevimab to pair with it, Lilly said. Etesevimab and bamlanivimab together neutralize more emerging Covid-19 variants in the U.S. than bamlanivimab alone, including the rapidly growing B.1.427/B.1.429 California strain, Lilly said on Friday. The drugmaker said it expects to make enough of the cocktail therapy along with partner Amgen to meet global supply needs.
Persons: Eli Lilly, Lilly, Amgen Organizations: Company, U.S . Food, Drug Administration, U.S Locations: Branchburg , New Jersey, U.S, California
Pusey, senior vice president of corporate affairs and communications, was one of Chief Executive Officer Dave Ricks’s first appointments upon taking the role in 2017. Elling had worked as an in-house lobbyist for Lilly since 2003, rising to become a senior director in 2005. O’Neail engaged in inappropriate sexual behavior in the office, including “sexual self-groping,” during meetings with Elling in her office, the lawsuit said. O’Neail was brought in to “clean house,” the lawsuit said, by terminating Elling and another employee, the lawsuit said. According to the suit, O’Neail falsely accused Elling of making disparaging statements about Lilly to congressional staff.
Persons: Eli Lilly, Mike Segar, Sonya Elling, Lilly, Leigh Ann Pusey, demeaned Elling, Elling, Pusey, Dave Ricks’s, “ Lilly, Kathryn Beiser, , Josh Smiley, Smiley, Donald Trump’s, ” Pusey, Shawn O’Neail, O’Neail Organizations: Reuters, Washington D.C, Company, REUTERS, Republican National Committee, Novartis AG, Pfizer Inc, Novartis Locations: Washington, Branchburg , New Jersey, New Jersey
Total: 14